Relapsed/Refractory Aggressive B-cell Lymphomas
1 clinical trials · Condition
◉ Watch Relapsed/Refractory Aggressive B-cell Lymphomas
| Record | Firm | Date |
|---|---|---|
| Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas (NCT02271945) | MedImmune LLC | 2014-12-01 |
Track Relapsed/Refractory Aggressive B-cell Lymphomas automatically
Every clearance here is in the API, with alerts when new ones post.